molmed

News & Events

Stay update

6th Annual Cell & Gene Therapy Investor Day 17 april NY ▾

6th Annual Cell & Gene Therapy Investor Day 17 april NY

Location: Metropolitan Club One East 60th Street New York, NY 10022

MolMed at this event: Company Presentation

Investors

MolMed and Orchard Therapeutics announce the beginning of their collaboration in the field of gene therapy for rare diseases

MolMed and Orchard Therapeutics announce the beginning of their collaboration in the field of gene therapy for rare diseases ▾

Investors

MolMed: the Shareholders’ Meeting approves 2017 Financial Statements

MolMed: the Shareholders’ Meeting approves 2017 Financial Statements ▾

Investors

Ordinary shareholders' meeting April 12 2018

Ordinary shareholders' meeting April 12 2018 ▾

Investors

Interim financial report as of March, 31st 2018

Interim financial report as of March, 31st 2018 ▾

Investors

Publication of documents for the annual general meeting to be held on April 12th, 2018

Publication of documents for the annual general meeting to be held on April 12th, 2018 ▾

Governance

Report on corporate governance and ownership structure 2017 (in Italian) ▾

Report on corporate governance and ownership structure 2017 (in Italian)

Governance

Annual remuneration report 2018 (in Italian) ▾

Annual remuneration report 2018 (in Italian)

Investors

MolMed presents at the 8th Advanced Therapies Summit in Amsterdam

MolMed presents at the 8th Advanced Therapies Summit in Amsterdam ▾

Investors

Call for the Shareholders’ Meeting on April, 12nd 2018

Call for the Shareholders’ Meeting on April, 12nd 2018 ▾

Subscribe to press releases

Dear Users, we would like to inform you that, as of 30 September, AGC Biologics S.p.A. (formerly MolMed S.p.A.) is no longer listed on the Milan Stock Exchange and has become part of the AGC Biologics Group. For any information on the company and the group, you are kindly invited to consult the websitewww.agcbio.com.
The contents present on this portal (www.molmed.com) are updated until the date of September 30, 2020 and will be available for the time frame foreseen by applicable regulations.
In addition, the "work with us" section is still active, while the contact details are no longer accessible.